Regulatory Approval

ECO Animal Health Group plc                    15 January 2010


                       ECO RECEIVES REGISTRATION APPROVAL
                         FOR TWO NEW AIVLOSIN® PRODUCTS


On  26  and  29  October  2009 ECO Animal Health Group plc  announced  that  its
subsidiary  ECO Animal Health Limited (ECO) had received positive opinions  from
the European Medicines Agency (EMEA) for two new products:

  ·    A concentrated form of Aivlosin® oral powder for pigs

  ·     Aivlosin®  granules for oral solution for medicated drinking  water  for
     pheasants

ECO  is  now  pleased  to  report  that  the  European  Commission  has  granted
registration  approval for both these products and this allows  the  company  to
commence active marketing of them throughout Europe.

The  European  Commission's approval marks yet another important step  in  ECO's
continuing  development  of  Aivlosin as a global veterinary  product.  It  will
further  extend  the  marketing  reach of Aivlosin®,  ECO's  patented  macrolide
antibiotic, which is used for the treatment of respiratory and enteric  diseases
in pigs and poultry.


Contacts:
ECO  Animal Health Group plc                          Marc Loomes     020 8447 8899


Spiro Financial                                       Anthony Spiro   020 8336 6196

Cenkos  Securities plc                                Stephen Keys    020 7397 8926
(Nominated Adviser)

ECO  Animal  Health Group plc is a leader in the development,  registration  and
marketing of pharmaceutical products for animals. Our products for these  global
growth markets promote well-being. Our financial goals are achieved through  the
careful  and  responsible  application of science  to  generate  value  for  our
shareholders.